cetylpyridinium chloride anhydrous has been researched along with rosiglitazone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aquilante, CL; Burt, LE; Bushman, LR; Knutsen, SD; Kosmiski, LA; Rome, LC | 1 |
1 trial(s) available for cetylpyridinium chloride anhydrous and rosiglitazone
Article | Year |
---|---|
Influence of SLCO1B1 and CYP2C8 gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers.
Topics: Adolescent; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C8; Female; Genotype; Health; Humans; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Organic Anion Transporters; Polymorphism, Genetic; Rosiglitazone; Thiazolidinediones; Time Factors | 2008 |